Details for New Drug Application (NDA): 065461
✉ Email this page to a colleague
The generic ingredient in TACROLIMUS is tacrolimus. There are twenty drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the tacrolimus profile page.
Summary for 065461
| Tradename: | TACROLIMUS |
| Applicant: | Sandoz |
| Ingredient: | tacrolimus |
| Patents: | 0 |
Pharmacology for NDA: 065461
| Mechanism of Action | Calcineurin Inhibitors |
Medical Subject Heading (MeSH) Categories for 065461
Suppliers and Packaging for NDA: 065461
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TACROLIMUS | tacrolimus | CAPSULE;ORAL | 065461 | ANDA | Sandoz Inc. | 0781-2102 | 0781-2102-01 | 100 CAPSULE in 1 BOTTLE (0781-2102-01) |
| TACROLIMUS | tacrolimus | CAPSULE;ORAL | 065461 | ANDA | Sandoz Inc. | 0781-2103 | 0781-2103-01 | 100 CAPSULE in 1 BOTTLE (0781-2103-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 0.5MG BASE | ||||
| Approval Date: | Aug 10, 2009 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 1MG BASE | ||||
| Approval Date: | Aug 10, 2009 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Aug 10, 2009 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
